228 related articles for article (PubMed ID: 34279177)
1. The Stockholm Spinal Cord Uro Study: 3. Urodynamic characteristics in a regional prevalence group of persons with spinal cord injury and indications for improved follow-up.
Farrelly E; Lindbo L; Seiger Å
Scand J Urol; 2021 Oct; 55(5):412-418. PubMed ID: 34279177
[TBL] [Abstract][Full Text] [Related]
2. Change in urodynamic pattern and incidence of urinary tract infection in patients with traumatic spinal cord injury practicing clean self-intermittent catheterization.
Neyaz O; Srikumar V; Equebal A; Biswas A
J Spinal Cord Med; 2020 May; 43(3):347-352. PubMed ID: 30277852
[No Abstract] [Full Text] [Related]
3. Renal deterioration after spinal cord injury is associated with length of detrusor contractions during cystometry-A study with a median of 41 years follow-up.
Elmelund M; Klarskov N; Bagi P; Oturai PS; Biering-Sørensen F
Neurourol Urodyn; 2017 Aug; 36(6):1607-1615. PubMed ID: 27813141
[TBL] [Abstract][Full Text] [Related]
4. Urodynamic Differences between Complete and Incomplete Spinal Cord Injuries with Neurogenic Detrusor Overactivity.
García Fadrique G; Gallego D; Ordaz D; Climent L
Urol Int; 2020; 104(3-4):273-276. PubMed ID: 31461727
[TBL] [Abstract][Full Text] [Related]
5. Detrusor Acontractility after Acute Spinal Cord Injury-Myth or Reality?
Bywater M; Tornic J; Mehnert U; Kessler TM
J Urol; 2018 Jun; 199(6):1565-1570. PubMed ID: 29352989
[TBL] [Abstract][Full Text] [Related]
6. Neurogenic detrusor overactivity: comparison between complete and incomplete spinal cord injury patients.
Moslavac S; Dzidic I; Kejla Z
Neurourol Urodyn; 2008; 27(6):504-6. PubMed ID: 18508334
[TBL] [Abstract][Full Text] [Related]
7. The Stockholm Spinal Cord Uro Study: 1. Basic characteristics and problem inventory.
Farrelly E; Lindbo L; Wijkström H; Seiger Å
Scand J Urol; 2019 Dec; 53(6):403-410. PubMed ID: 31630596
[No Abstract] [Full Text] [Related]
8. Injections of Botulinum Toxin A into the detrusor to treat neurogenic detrusor overactivity secondary to spinal cord injury.
Chen G; Liao L
Int Urol Nephrol; 2011 Sep; 43(3):655-62. PubMed ID: 21110094
[TBL] [Abstract][Full Text] [Related]
9. Six-year follow-up of botulinum toxin A intradetrusorial injections in patients with refractory neurogenic detrusor overactivity: clinical and urodynamic results.
Giannantoni A; Mearini E; Del Zingaro M; Porena M
Eur Urol; 2009 Mar; 55(3):705-11. PubMed ID: 18814955
[TBL] [Abstract][Full Text] [Related]
10. Are oxybutynin and trospium efficacious in the treatment of detrusor overactivity in spinal cord injury patients?
Hadiji N; Previnaire JG; Benbouzid R; Robain G; Leblond C; Mieusset R; Enjalbert M; Soler JM
Spinal Cord; 2014 Sep; 52(9):701-5. PubMed ID: 25047051
[TBL] [Abstract][Full Text] [Related]
11. Epidemiology and pathophysiology of neurogenic bladder after spinal cord injury.
Hamid R; Averbeck MA; Chiang H; Garcia A; Al Mousa RT; Oh SJ; Patel A; Plata M; Del Popolo G
World J Urol; 2018 Oct; 36(10):1517-1527. PubMed ID: 29752515
[TBL] [Abstract][Full Text] [Related]
12. Temporal development of unfavourable urodynamic parameters during the first year after spinal cord injury.
Anderson CE; Kozomara M; Birkhäuser V; Bywater M; Gross O; Kiss S; Knüpfer SC; Koschorke M; Leitner L; Mehnert U; Sadri H; Sammer U; Stächele L; Tornic J; Liechti MD; Brinkhof MWG; Kessler TM
BJU Int; 2023 Apr; 131(4):503-512. PubMed ID: 36221991
[TBL] [Abstract][Full Text] [Related]
13. Effects of solifenacin in patients with neurogenic detrusor overactivity as a result of spinal cord lesion.
Krebs J; Pannek J
Spinal Cord; 2013 Apr; 51(4):306-9. PubMed ID: 23247012
[TBL] [Abstract][Full Text] [Related]
14. Video-Urodynamic Characteristics and Predictors of Switching from Botulinum Neurotoxin a Injection to Augmentation Enterocystoplasty in Spinal Cord Injury Patients.
Lin CC; Kuo HC
Toxins (Basel); 2022 Jan; 14(1):. PubMed ID: 35051024
[TBL] [Abstract][Full Text] [Related]
15. Injecting RNA interference lentiviruses targeting the muscarinic 3 receptor gene into the bladder wall inhibits neurogenic detrusor overactivity in rats with spinal cord injury.
Shang Z; Jia C; Yan H; Cui B; Wu J; Wang Q; Gao W; Cui X; Li J; Ou T
Neurourol Urodyn; 2019 Feb; 38(2):615-624. PubMed ID: 30549314
[TBL] [Abstract][Full Text] [Related]
16. Urodynamic findings in patients with complete and incomplete suprasacral spinal cord injury at different stages after injury.
Lu J; Cheng B; Lin L; Yue S
Ann Palliat Med; 2021 Mar; 10(3):3171-3178. PubMed ID: 33849102
[TBL] [Abstract][Full Text] [Related]
17. Meta-analysis of botulinum toxin A detrusor injections in the treatment of neurogenic detrusor overactivity after spinal cord injury.
Mehta S; Hill D; McIntyre A; Foley N; Hsieh J; Ethans K; Teasell RW; Loh E; Welk B; Wolfe D
Arch Phys Med Rehabil; 2013 Aug; 94(8):1473-81. PubMed ID: 23632286
[TBL] [Abstract][Full Text] [Related]
18. Effects of repetitive functional magnetic stimulation in the sacral nerve in patients with neurogenic detrusor overactivity after suprasacral spinal cord injury: a study protocol for a randomized controlled trial.
Li J; Wang J; Hu Y; Jian R; Zhao Y; Li D; Wan T; Jike W; Xu F; Huang M
Trials; 2023 Mar; 24(1):199. PubMed ID: 36932375
[TBL] [Abstract][Full Text] [Related]
19. OnabotulinumtoxinA improves urodynamic outcomes in patients with neurogenic detrusor overactivity.
Rovner E; Dmochowski R; Chapple C; Thompson C; Lam W; Haag-Molkenteller C
Neurourol Urodyn; 2013 Nov; 32(8):1109-15. PubMed ID: 23389824
[TBL] [Abstract][Full Text] [Related]
20. Effects of Bilateral Transcutaneous Tibial Nerve Stimulation on Neurogenic Detrusor Overactivity in Spinal Cord Injury: A Urodynamic Study.
Kamboonlert K; Panyasriwanit S; Tantisiriwat N; Kitisomprayoonkul W
Arch Phys Med Rehabil; 2021 Jun; 102(6):1165-1169. PubMed ID: 33245938
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
